O=C(NN1C(=O)c2cc(Br)ccc2NC1c1c(O)ccc2ccccc12)c1ccc2c(c1)OCO2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?